National Health Act 1953 - Amendment declaration under subsections 85(2) and 85(2AA) - Amendment determination under subsection 85(2A) - drugs and medicinal preparations (No. PB 67 of 2010)

Overview

The National Health Act 1953 Amendment Declaration under subsections 85(2) and 85(2AA) and the amendment determination under subsection 85(2A), implemented by the legislative instrument F2010L02059, was enacted in 2010 to provide reliable, timely, and affordable access to a wide range of medicines for all Australians through the Pharmaceutical Benefits Scheme (PBS). The Act, administered by the Parliament of Australia, aims to ensure that drugs and medicinal preparations are available as pharmaceutical benefits under the PBS, in accordance with recommendations from the Pharmaceutical Benefits Advisory Committee (PBAC). This legislative instrument amends previous declarations and determinations to update the list of drugs and medicinal preparations available as pharmaceutical benefits, as well as the circumstances in which these benefits may be prescribed, based on PBAC recommendations. The changes include the addition of new drugs and medicinal preparations, alteration of the circumstances for certain drugs, and changes to the form and manner of administration of pharmaceutical items. The amendments declared by this instrument are intended to ensure that the PBS remains responsive to the evolving healthcare needs of Australians, maintaining a balance between providing access to new and effective treatments, and ensuring the sustainability and affordability of the scheme. The PBAC plays a crucial role in advising the Minister on which drugs and medicinal preparations should be included in the PBS, taking into account factors such as clinical effectiveness, safety, and cost-effectiveness. This instrument reflects the ongoing commitment of the Australian Government to provide equitable access to necessary medications, while also ensuring the efficient use of public funds.

Scope and Application

The National Health Act 1953, as amended by legislative instrument number PB 67 of 2010, governs the Pharmaceutical Benefits Scheme (PBS), which ensures Australians have affordable access to a range of medicines. Under this Act, the Minister declares drugs and medicinal preparations available as pharmaceutical benefits by legislative instrument, listing these in Schedules of the Act. The amendments made by PB 67 of 2010, which came into effect on 1 August 2010, adjust the list of drugs and the conditions under which they can be prescribed as pharmaceutical benefits, in line with recommendations from the Pharmaceutical Benefits Advisory Committee (PBAC). The PBAC, an independent body comprising experts from various health-related fields, advises the Minister on which drugs should be included in the PBS. The amendments include adding new drugs to the PBS, altering the circumstances under which certain drugs can be prescribed, and modifying the forms and strengths of some drugs. These changes are detailed in Schedule 1 of the instrument.

Key Provisions

The main operative sections of this legislation concern amendments to the list of drugs and medicinal preparations available as pharmaceutical benefits under the National Health Act 1953, as well as changes to the circumstances in which these benefits may be prescribed (Schedule 1). These changes are based on recommendations from the Pharmaceutical Benefits Advisory Committee (PBAC) and are designed to ensure that the Pharmaceutical Benefits Scheme (PBS) continues to provide timely and affordable access to a wide range of medicines for Australians. The Minister is empowered by subsection 85(2) to declare the drugs and medicinal preparations that are available as pharmaceutical benefits, and subsection 85(2AA) allows for the revocation or variation of these declarations. The amendments also specify the form or manner of administration of these drugs and the brands that constitute the pharmaceutical benefit (subsections 85(3), 85(5), and 85(6)). Any revocation or variation that would result in a drug or medicinal preparation ceasing to be a listed drug requires written advice from the PBAC, which must be tabled in Parliament (subsections 85(2AB) and 85(2AC)). The Act imposes several obligations on parties and entities it governs. The Minister is required to consult with the PBAC when considering amendments to the list of drugs and medicinal preparations available as pharmaceutical benefits, as the PBAC provides expert recommendations based on clinical effectiveness, safety, and cost-effectiveness. The Minister must also obtain written advice from the PBAC and table it in Parliament if any amendment would result in a drug or medicinal preparation ceasing to be a listed drug. The PBAC, in turn, is responsible for making recommendations to the Minister about which drugs and medicinal preparations should be available as pharmaceutical benefits, taking into account the medical conditions for which the medicine has been approved for use in Australia, its clinical effectiveness, safety, and cost-effectiveness compared with other treatments. These obligations ensure that the PBS remains a reliable and effective system for providing access to essential medicines. The Act also outlines potential offences, penalties, or civil/criminal consequences for breaches. However, the specific provisions detailing offences, penalties, or consequences are not provided in the text. In general, breaches of the National Health Act 1953 or any related regulations could result in penalties under the relevant legislation, which may include fines or other civil or criminal sanctions. The maximum penalties would depend on the specific nature of the breach and the provisions of the applicable laws. It is important for parties and entities governed by the Act to comply with its requirements to avoid potential legal consequences.